Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2011 1
2014 1
2015 1
2018 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Guidelines for diagnostics and treatment of aromatase inhibitor-induced bone loss in women with breast cancer: a consensus of Lithuanian medical oncologists, radiation oncologists, endocrinologists, and family medicine physicians.
Juozaitytė E, Aleknavičius E, Jančiauskienė R, Cesas A, Pipirienė-Želvienė T, Liutkauskienė S, Krasauskienė A, Vencevičienė L. Juozaitytė E, et al. Among authors: liutkauskiene s. Medicina (Kaunas). 2014;50(4):197-203. doi: 10.1016/j.medici.2014.09.004. Epub 2014 Oct 1. Medicina (Kaunas). 2014. PMID: 25458955 Free article.
Sequential treatment of metastatic renal cell carcinoma patients after first-line vascular endothelial growth factor targeted therapy in a real-world setting: epidemiologic, noninterventional, retrospective-prospective cohort multicentre study.
Cesas A, Urbonas V, Tulyte S, Janciauskiene R, Liutkauskiene S, Grabauskyte I, Gaidamavicius I. Cesas A, et al. Among authors: liutkauskiene s. J Cancer Res Clin Oncol. 2023 Aug;149(10):6979-6988. doi: 10.1007/s00432-023-04645-x. Epub 2023 Feb 27. J Cancer Res Clin Oncol. 2023. PMID: 36847839 Free PMC article.
An open-label multicenter safety, tolerability, and efficacy study of recombinant granulocyte colony-stimulating factor in the prevention of neutropenic complications in breast cancer patients.
Sveikata A, Liutkauskienė S, Juozaitytė E, Characiejus D, Tamošaitytė L, Šeštakauskas K. Sveikata A, et al. Among authors: liutkauskiene s. Medicina (Kaunas). 2011;47(8):428-33. Epub 2011 Nov 18. Medicina (Kaunas). 2011. PMID: 22123557 Free article. Clinical Trial.